240 related articles for article (PubMed ID: 1079429)
1. Activation of T-cells rosettes in immunodeficient patients by thymosin.
Wara DW; Ammann AJ
Ann N Y Acad Sci; 1975 Feb; 249():308-15. PubMed ID: 1079429
[No Abstract] [Full Text] [Related]
2. The primary immunodeficiency diseases: classification, pathogenesis and treatment.
Gatti RA; Seligmann M
Turk J Pediatr; 1973 Oct; 15(4):195-215. PubMed ID: 4600502
[No Abstract] [Full Text] [Related]
3. [Primary immunodeficient syndromes].
Stoppoloni G
Pediatria (Napoli); 1973 Mar; 81(1):147-200. PubMed ID: 4578105
[No Abstract] [Full Text] [Related]
4. Thymosin activity in patients with cellular immunodeficiency.
Wara DW; Goldstein AL; Doyle NE; Ammann AJ
N Engl J Med; 1975 Jan; 292(2):70-4. PubMed ID: 1078552
[TBL] [Abstract][Full Text] [Related]
5. Immune deficiency diseases.
Hitzig WH
J Clin Pathol Suppl (Assoc Clin Pathol); 1975; 6():83-91. PubMed ID: 802876
[No Abstract] [Full Text] [Related]
6. T and B markers in immunodeficiencies.
Griscelli C
Birth Defects Orig Artic Ser; 1975; 11(1):45-9. PubMed ID: 1096991
[No Abstract] [Full Text] [Related]
7. Immunodeficiency disease and malignancy. Various immunologic deficiencies of man and the role of immune processes in the control of malignant disease.
Ann Intern Med; 1972 Oct; 77(4):605-28. PubMed ID: 4581908
[No Abstract] [Full Text] [Related]
8. Immunodeficiency disorders.
Asherson GL
Practitioner; 1975 Apr; 214(1282):494-501. PubMed ID: 1144262
[No Abstract] [Full Text] [Related]
9. [Classification of immuno-deficiency diseases].
Nezelof C
Arch Fr Pediatr; 1968; 25(7):781-825. PubMed ID: 4177610
[No Abstract] [Full Text] [Related]
10. Lymphocyte markers for B- and T-cells in primary immunodeficiency diseases.
Schwenk HU; Gimpert E; Plüss HJ; Pilgrim U; Hitzig WH
Klin Wochenschr; 1974 May; 52(9):426-32. PubMed ID: 4606774
[No Abstract] [Full Text] [Related]
11. The primary immunodeficiencies: dermatologic manifestations.
Rosen FS
J Invest Dermatol; 1976 Sep; 67(3):402-11. PubMed ID: 787434
[No Abstract] [Full Text] [Related]
12. Effect of thymic factors on the differentiation of human marrow cells into T-lympnocytes in vitro in normals and patients with immunodeficiencies.
Touraine JL; Touraine F; Incefy GS; Good RA
Ann N Y Acad Sci; 1975 Feb; 249():335-42. PubMed ID: 48353
[No Abstract] [Full Text] [Related]
13. [Clinical aspects of immunologic diseases in children].
Barandun S
Med Welt; 1972 Oct; 23(43):1533-5. PubMed ID: 5086318
[No Abstract] [Full Text] [Related]
14. Immunodeficiency in developmental perspective.
Good RA
Harvey Lect; 1973; 67():1-107. PubMed ID: 4581934
[No Abstract] [Full Text] [Related]
15. Editorial: Thymosin therapy creates a "Hassall"(?).
Hong R; Horowitz S
N Engl J Med; 1975 Jan; 292(2):104-5. PubMed ID: 1078550
[No Abstract] [Full Text] [Related]
16. Primary immunodeficiency.
Rosen FS
Pediatr Clin North Am; 1974 Aug; 21(3):533-49. PubMed ID: 4137895
[No Abstract] [Full Text] [Related]
17. Disorders of host defense against infection. Pathophysiologic and diagnostic considerations.
Johnston RB; Lawton AR; Cooper MD
Med Clin North Am; 1973 Mar; 57(2):421-40. PubMed ID: 4571800
[No Abstract] [Full Text] [Related]
18. Occurrence of malignancy in immunodeficiency diseases. A literature review.
Gatti RA; Good RA
Cancer; 1971 Jul; 28(1):89-98. PubMed ID: 4938894
[No Abstract] [Full Text] [Related]
19. The prevalence of autoantibodies in T-cell, B-cell, and phagocytic immunodeficiency disorders.
Ammann AJ; Wara DW; Pillarisetty RJ; Talal N
Clin Immunol Immunopathol; 1979 Dec; 14(4):456-66. PubMed ID: 315850
[No Abstract] [Full Text] [Related]
20. [Immunological deficiencies in childhood. Clinical aspects and attempted nosological classification of primary specific immunodeficiencies].
Zannino L
Arch Sci Med (Torino); 1978; 135(1):99-135. PubMed ID: 346001
[No Abstract] [Full Text] [Related]
[Next] [New Search]
